Okupe Oluyemi 4

What Happened
Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, exercised stock options and sold the resulting 5,262 shares. The option exercise recorded an acquisition cost of $5.01 per share (total $26,363), and the same 5,262 shares were sold in the open market at an average weighted price of $26.44 per share for gross proceeds of about $139,108. The transactions were reported on a Form 4 filed Feb 4, 2026 covering activity on Feb 3, 2026.

Key Details

• Transaction date: February 3, 2026 (Form 4 filed Feb 4, 2026)
• Exercise (code M): 5,262 shares acquired at $5.01 each = $26,363
• Sale (code S): 5,262 shares sold at an average $26.44 each = $139,108 (shares sold in range $26.35–$26.56)
• A derivative conversion line shows 5,262 shares disposed at $0.00 (reporting the exercised/converted derivative)
• Sales were effected under a Rule 10b5‑1 trading plan adopted May 21, 2025 (footnote F1)
• Shares owned after the transaction: not specified in the provided excerpt
• Filing appears timely (transaction on 2/3/2026; Form 4 filed 2/4/2026)

Context
The filing shows an option exercise followed by an immediate sale of the resulting shares — a common pattern when insiders exercise options and then sell shares to cover costs or diversify. The reported use of a 10b5‑1 plan indicates the sales were prearranged under an established trading plan. Footnote F3 notes the underlying options vest monthly over a four‑year schedule; footnote F2 provides the sale price range and offers to provide per‑price breakdowns on request.